Leeward Investments LLC MA lowered its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 7.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 401,629 shares of the company's stock after selling 31,283 shares during the period. Leeward Investments LLC MA owned 0.24% of Option Care Health worth $9,318,000 at the end of the most recent quarter.
Other large investors also recently added to or reduced their stakes in the company. Olympiad Research LP acquired a new position in shares of Option Care Health during the 4th quarter valued at about $360,000. New York State Common Retirement Fund raised its stake in Option Care Health by 14.6% during the fourth quarter. New York State Common Retirement Fund now owns 246,034 shares of the company's stock worth $5,708,000 after purchasing an additional 31,400 shares during the period. Kornitzer Capital Management Inc. KS boosted its holdings in Option Care Health by 2.5% in the 4th quarter. Kornitzer Capital Management Inc. KS now owns 444,095 shares of the company's stock valued at $10,303,000 after purchasing an additional 10,900 shares during the last quarter. Venturi Wealth Management LLC grew its stake in shares of Option Care Health by 2,621.3% in the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock valued at $110,000 after buying an additional 4,561 shares during the period. Finally, Principal Financial Group Inc. grew its stake in shares of Option Care Health by 0.9% in the 4th quarter. Principal Financial Group Inc. now owns 479,255 shares of the company's stock valued at $11,119,000 after buying an additional 4,166 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research analysts recently commented on the company. JMP Securities reiterated a "market outperform" rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Truist Financial decreased their price target on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research note on Friday, November 1st. Barrington Research raised their price objective on Option Care Health from $32.00 to $33.00 and gave the stock an "outperform" rating in a research report on Tuesday, January 14th. The Goldman Sachs Group lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $38.00 to $27.00 in a report on Monday, November 4th. Finally, JPMorgan Chase & Co. increased their target price on shares of Option Care Health from $38.00 to $40.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Option Care Health has a consensus rating of "Moderate Buy" and a consensus price target of $32.25.
Read Our Latest Report on Option Care Health
Option Care Health Trading Up 1.6 %
NASDAQ:OPCH traded up $0.52 on Wednesday, reaching $33.15. 3,231,229 shares of the company's stock were exchanged, compared to its average volume of 1,784,022. The firm has a market capitalization of $5.64 billion, a price-to-earnings ratio of 27.86, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $34.17. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The business has a fifty day moving average of $28.07 and a 200-day moving average of $28.00.
Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.35 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.02. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. As a group, analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.